Abstract
The use of nitric oxide as an agent to reduce pulmonary artery pressure in a pregnancy
complicated by pulmonary hypertension is reported for the first time. This therapy
can reduce pulmonary vascular resistance and therefore potentially enable the right
ventricle to better compensate for the physiologic changes of pregnancy. (Am J Obstet
Gynecol 1999;180:1045-6.)
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Obstetrics & GynecologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Hemodynamic and inotropic effects of nitric oxide in pulmonary hypertension.J Surg Res. 1997; 69: 288-294
- Pulsed delivery of inhaled nitric oxide to patients with primary pulmonary hypertension: an ambulatory delivery system and initial clinical tests.Chest. 1996; 109: 1545-1549
Article Info
Publication History
Accepted:
December 28,
1998
Received:
October 30,
1998
Footnotes
☆Reprint requests: Julian N. Robinson, MD, Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Brigham & Women’s Hospital, 75 Francis St, Boston, MA 02115.
☆☆0002-9378/99 $8.00 + 06/1/96749
Identification
Copyright
© 1999 Mosby, Inc. Published by Elsevier Inc. All rights reserved.
